Literature DB >> 16896108

Recalls and safety alerts affecting automated external defibrillators.

Jignesh S Shah1, William H Maisel.   

Abstract

CONTEXT: Automated external defibrillators (AEDs) play a key role in the community resuscitation of persons with cardiac arrest and are of proven clinical benefit. Although AEDs are complex medical devices designed to function during life-threatening emergencies, little is known about their reliability.
OBJECTIVES: To determine the number and rate of AED recalls and safety alerts, to identify trends in these rates, and to identify the types of malfunctions prompting AED and AED accessory advisories. DESIGN AND
SETTING: Analysis of weekly US Food and Drug Administration (FDA) Enforcement Reports between January 1996 and December 2005 was performed to identify all recalls and safety alerts (collectively referred to as "advisories") involving AEDs and AED accessories. Confirmed AED device malfunctions were identified by reviewing AED-related adverse events reported to the FDA. MAIN OUTCOME MEASURES: Number of AEDs and AED accessories subject to FDA recall or safety alert between January 1996 and December 2005; annual AED advisory rates; and number of confirmed fatal AED-related device malfunctions reported to the FDA.
RESULTS: During 2.78 million AED device-years of observation, 52 advisories (median [25th and 75th percentiles], 4.5 [3.0 and 5.0] per year) affecting 385,922 AEDs and AED accessories were issued. The mean (SE) annual number of AEDs affected by advisories was 5.1 (1.5) devices per 100 AED device-years. Overall, 21.2% of AEDs distributed during the study period were recalled, most often because of electrical or software problems. The AED advisory rate did not significantly increase during the study period, although the annual number of AED advisories (P for trend =.02) and AED advisory devices (P for trend = .01) did increase. Confirmed fatal AED-related device malfunctions occurred in 370 patients.
CONCLUSIONS: Automated external defibrillators and AED accessory advisories occur frequently and affect many devices. Actual AED malfunctions do occur occasionally, although the number of observed malfunctions is small compared with the number of lives saved by these important devices. As the prevalence of AEDs continues to increase, the number of devices affected by advisories can also be expected to increase. Efforts should be directed at developing a reliable system to locate and repair potentially defective devices in a timely fashion.

Entities:  

Mesh:

Year:  2006        PMID: 16896108     DOI: 10.1001/jama.296.6.655

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Public health surveillance and the prevention of injuries in sports: what gets measured gets done.

Authors:  Stephen B Thacker
Journal:  J Athl Train       Date:  2007 Apr-Jun       Impact factor: 2.860

2.  Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million.

Authors:  Myron L Weisfeldt; Colleen M Sitlani; Joseph P Ornato; Thomas Rea; Tom P Aufderheide; Daniel Davis; Jonathan Dreyer; Erik P Hess; Jonathan Jui; Justin Maloney; George Sopko; Judy Powell; Graham Nichol; Laurie J Morrison
Journal:  J Am Coll Cardiol       Date:  2010-04-20       Impact factor: 24.094

3.  An evaluation of a distributed medical device safety surveillance system: the DELTA network study.

Authors:  Venkatesan D Vidi; Michael E Matheny; Sharon Donnelly; Frederic S Resnic
Journal:  Contemp Clin Trials       Date:  2011-02-26       Impact factor: 2.226

4.  Registry-Based Prospective, Active Surveillance of Medical-Device Safety.

Authors:  Frederic S Resnic; Arjun Majithia; Danica Marinac-Dabic; Susan Robbins; Henry Ssemaganda; Kathleen Hewitt; Angelo Ponirakis; Nilsa Loyo-Berrios; Issam Moussa; Joseph Drozda; Sharon-Lise Normand; Michael E Matheny
Journal:  N Engl J Med       Date:  2017-01-25       Impact factor: 91.245

5.  Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.

Authors:  Frederic S Resnic; Thomas P Gross; Danica Marinac-Dabic; Nilsa Loyo-Berrios; Sharon Donnelly; Sharon-Lise T Normand; Michael E Matheny
Journal:  JAMA       Date:  2010-11-10       Impact factor: 56.272

6.  Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

Authors:  Frederic S Resnic; Arjun Majithia; Sanket S Dhruva; Henry Ssemaganda; Susan Robbins; Danica Marinac-Dabic; Kathleen Hewitt; Lucila Ohno-Machado; Matthew R Reynolds; Michael E Matheny
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-04-14

7.  The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors:  Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-12-09

8.  Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests.

Authors:  Ross A Pollack; Siobhan P Brown; Thomas Rea; Tom Aufderheide; David Barbic; Jason E Buick; Jim Christenson; Ahamed H Idris; Jamie Jasti; Michael Kampp; Peter Kudenchuk; Susanne May; Marc Muhr; Graham Nichol; Joseph P Ornato; George Sopko; Christian Vaillancourt; Laurie Morrison; Myron Weisfeldt
Journal:  Circulation       Date:  2018-02-26       Impact factor: 29.690

9.  Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance.

Authors:  Daniel B Kramer; Matthew Baker; Benjamin Ransford; Andres Molina-Markham; Quinn Stewart; Kevin Fu; Matthew R Reynolds
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  A summary of public access defibrillation laws, United States, 2010.

Authors:  Siobhan Gilchrist; Linda Schieb; Qaiser Mukhtar; Amy Valderrama; Guangyu Zhang; Paula Yoon; Michael Schooley
Journal:  Prev Chronic Dis       Date:  2012-03-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.